(Q44513291)

3 December 2017

Polyreactive autoantibodies purified from human intravenous immunoglobulins prevent the development of experimental autoimmune diseases (English)

1 reference

3 December 2017

1 reference

Martine Bruley-Rosset

1

1 reference

3 December 2017

Luc Mouthon

2

1 reference

3 December 2017

Youri Chanseaud

3

1 reference

3 December 2017

Frédéric Dhainaut

4

1 reference

3 December 2017

Jacky Lirochon

5

1 reference

3 December 2017

Dominique Bourel

6

1 reference

3 December 2017

1 July 2003

1 reference

3 December 2017

Laboratory Investigation

1 reference

3 December 2017

83

1 reference

3 December 2017

1013-1023

1 reference

3 December 2017

7

1 reference

https://scigraph.springernature.com/pub.10.1097/01.lab.0000077982.70800.02

3 December 2017

0 references

cites work

Anti-cytokine nature of natural human immunoglobulin: one possible mechanism of the clinical effect of intravenous immunoglobulin therapy

1 reference

https://api.crossref.org/works/10.1097%2F01.LAB.0000077982.70800.02

Pooled human IgG modulates cytokine production in lymphocytes and monocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.LAB.0000077982.70800.02

IgG induction of IL-1 receptor antagonist production by human monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.LAB.0000077982.70800.02

Natural mouse IgG reacts with self antigens including molecules involved in the immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.LAB.0000077982.70800.02

21 January 2018

Natural autoantibodies.

1 reference

https://api.crossref.org/works/10.1097%2F01.LAB.0000077982.70800.02

Intravenous immune globulin therapy for neurologic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.LAB.0000077982.70800.02

A V region-connected autoreactive subfraction of normal human serum immunoglobulin G.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.LAB.0000077982.70800.02

Manipulating the Immune System with Immune Globulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.LAB.0000077982.70800.02

Immunoglobulin-mediated prevention of autoimmune diabetes in the non-obese diabetic (NOD) mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.LAB.0000077982.70800.02

V region-mediated selection of autoreactive repertoires by intravenous immunoglobulin (i.v.Ig).

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.LAB.0000077982.70800.02

Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.LAB.0000077982.70800.02

Mechanisms of intravenous immunoglobulin action in the treatment of autoimmune disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.LAB.0000077982.70800.02

Monocyte-macrophage system as targets for immunomodulation by intravenous immunoglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.LAB.0000077982.70800.02

Anti-idiotypes against anti-neutrophil cytoplasmic antigen autoantibodies in normal human polyspecific IgG for therapeutic use and in the remission sera of patients with systemic vasculitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.LAB.0000077982.70800.02

Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.LAB.0000077982.70800.02

Immunoglobulins from rats that are resistant to adjuvant arthritis suppress the disease in arthritis-susceptible rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.LAB.0000077982.70800.02

Selective induction of interleukin-1 receptor antagonist and interleukin-8 in human monocytes by normal polyspecific IgG (intravenous immunoglobulin)

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.LAB.0000077982.70800.02

Self-reactive antibodies (natural autoantibodies) in healthy individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.LAB.0000077982.70800.02

Suppression of experimental autoimmune encephalomyelitis by intravenously administered polyclonal immunoglobulins

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.LAB.0000077982.70800.02

Monoclonal, natural antibodies prevent development of diabetes in the non-obese diabetic (NOD) mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.LAB.0000077982.70800.02

IgG auto- and polyreactivities of normal human sera

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.LAB.0000077982.70800.02

Positive selection of natural autoreactive B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.LAB.0000077982.70800.02

Monoclonal anti-idiotypic antibodies against human anti-thyroglobulin autoantibodies recognize idiotopes shared by disease-associated and natural anti-thyroglobulin autoantibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.LAB.0000077982.70800.02

Polyreactivity as an acquired artefact, rather than a physiologic property, of antibodies: evidence that monoreactive antibodies may gain the ability to bind to multiple antigens after exposure to low pH

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.LAB.0000077982.70800.02

Suppressive effect of intravenous immunoglobulins on the activity of interleukin-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.LAB.0000077982.70800.02

Polyvalent immunoglobulin for intravenous use interferes with cell proliferation in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.LAB.0000077982.70800.02

Anti-suppressor effect of cyclophosphamide on the development of spontaneous diabetes in NOD mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.LAB.0000077982.70800.02

Mechanism of intravenous immune globulin therapy in antibody-mediated autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.LAB.0000077982.70800.02

10.1097/01.LAB.0000077982.70800.02

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

3 December 2017

0 references

1 reference